Clay Thorp - 03 Jun 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role
Director
Signature
/s/ John P. Sharp, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
03 Jun 2021
Net transactions value
$0
Form type
4
Filing time
04 Jun 2021, 18:03:57 UTC
Previous filing
19 Dec 2022
Next filing
11 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Non-employee Director Stock Option (right to buy) Award $0 +14,000 $0.000000 14,000 03 Jun 2021 Common Stock 14,000 $3.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2022 annual meeting, subject to the reporting person's continuous service through each such date